Share on StockTwits

Stock analysts at Canaccord Genuity dropped their target price on shares of Immunodiagnostic Systems Hldgs PLC (LON:IDH) from GBX 492 ($8.25) to GBX 478 ($8.02) in a report issued on Tuesday. The firm currently has a “hold” rating on the stock. Canaccord Genuity’s price objective would indicate a potential downside of 0.42% from the company’s current price.

Immunodiagnostic Systems Hldgs PLC (LON:IDH) opened at 480.00 on Tuesday. Immunodiagnostic Systems Hldgs PLC has a 52-week low of GBX 412.00 and a 52-week high of GBX 593.00. The stock’s 50-day moving average is GBX 522.8 and its 200-day moving average is GBX 526.2.

IDH has been the subject of a number of other recent research reports. Analysts at Panmure Gordon reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Monday, August 4th. They now have a GBX 600 ($10.07) price target on the stock. Separately, analysts at N+1 Singer downgraded shares of Immunodiagnostic Systems Hldgs PLC to a “sell” rating in a research note on Monday, August 4th. They now have a GBX 480 ($8.05) price target on the stock, down previously from GBX 525 ($8.81). Finally, analysts at FinnCap reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Monday, August 4th. They now have a GBX 500 ($8.39) price target on the stock. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of GBX 509.33 ($8.54).

Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.